To assess potential long-term effects of anthracycline treatment, tumor samples collected from 30 patients with locally advanced breast cancers, before and after 16 weeks of doxorubicin [30, 31], were examined for long-term gene expression changes of PTEN and AKT1 (Supplementary Figure 5). The gene discussed is PTEN; the disease is breast carcinoma.